Mid-regional Proadrenomedullin Biomarker Predicts Coronavirus Disease 2019 Clinical Outcomes: A US-Based Cohort Study

BACKGROUND: Mid-regional proadrenomedullin (MR-proADM) is a biomarker released following endothelial damage. Studies have shown a correlation in predicting coronavirus disease 2019 (COVID-19) outcomes with MR-proADM levels. Our study aimed to investigate baseline MR-proADM as a predictor of a wider...

Descripción completa

Detalles Bibliográficos
Autores principales: Atallah, Natalie J, Panossian, Vahe S, Atallah, Christine J, Schwabe, Andrej, Johannes, Sascha, Wiemer, Jan, Mansour, Michael K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439577/
https://www.ncbi.nlm.nih.gov/pubmed/36072696
http://dx.doi.org/10.1093/ofid/ofac423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439577/
https://www.ncbi.nlm.nih.gov/pubmed/36072696
http://dx.doi.org/10.1093/ofid/ofac423

Ejemplares similares